rocuronium and Metabolism--Inborn-Errors

rocuronium has been researched along with Metabolism--Inborn-Errors* in 2 studies

Other Studies

2 other study(ies) available for rocuronium and Metabolism--Inborn-Errors

Article	Year
Rocuronium-sugammadex use in electroconvulsive therapy of patients with pseudocholinesterase enzyme deficiency. Journal of clinical anesthesia, 2013, Volume: 25, Issue:8 Topics: Androstanols; Apnea; Butyrylcholinesterase; Contraindications; Electroconvulsive Therapy; gamma-Cyclodextrins; Humans; Male; Metabolism, Inborn Errors; Middle Aged; Neuromuscular Nondepolarizing Agents; Rocuronium; Succinylcholine; Sugammadex	2013
Rocuronium antagonized by sugammadex for series of electroconvulsive therapy (ECT) in a patient with pseudocholinesterase deficiency. The journal of ECT, 2011, Volume: 27, Issue:1 We report the anesthetic management of a patient with catatonic schizophrenia and pseudocholinesterase deficiency, using the nondepolarizing neuromuscular blocking drug, rocuronium, reversed by its specific reversal agent, sugammadex, for a series of electroconvulsive therapy sessions. Rocuronium and sugammadex were used every 48 hours for 8 consecutive times and proved to be an effective and safe combination in a situation where succinylcholine was contraindicated. Topics: Adult; Androstanols; Apnea; Butyrylcholinesterase; Cholinesterases; Drug Hypersensitivity; Drug Interactions; Electroconvulsive Therapy; gamma-Cyclodextrins; Humans; Male; Metabolism, Inborn Errors; Neuromuscular Nondepolarizing Agents; Rocuronium; Schizophrenia, Catatonic; Sugammadex	2011

Article

Year

Rocuronium-sugammadex use in electroconvulsive therapy of patients with pseudocholinesterase enzyme deficiency.

Journal of clinical anesthesia, 2013, Volume: 25, Issue:8

Topics: Androstanols; Apnea; Butyrylcholinesterase; Contraindications; Electroconvulsive Therapy; gamma-Cyclodextrins; Humans; Male; Metabolism, Inborn Errors; Middle Aged; Neuromuscular Nondepolarizing Agents; Rocuronium; Succinylcholine; Sugammadex

2013

Rocuronium antagonized by sugammadex for series of electroconvulsive therapy (ECT) in a patient with pseudocholinesterase deficiency.

The journal of ECT, 2011, Volume: 27, Issue:1

We report the anesthetic management of a patient with catatonic schizophrenia and pseudocholinesterase deficiency, using the nondepolarizing neuromuscular blocking drug, rocuronium, reversed by its specific reversal agent, sugammadex, for a series of electroconvulsive therapy sessions. Rocuronium and sugammadex were used every 48 hours for 8 consecutive times and proved to be an effective and safe combination in a situation where succinylcholine was contraindicated.

Topics: Adult; Androstanols; Apnea; Butyrylcholinesterase; Cholinesterases; Drug Hypersensitivity; Drug Interactions; Electroconvulsive Therapy; gamma-Cyclodextrins; Humans; Male; Metabolism, Inborn Errors; Neuromuscular Nondepolarizing Agents; Rocuronium; Schizophrenia, Catatonic; Sugammadex

2011